Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lundbeck says FDA accepts review of schizophrenia drug
Lundbeck says FDA accepts review of schizophrenia drug
Lundbeck says FDA accepts review of schizophrenia drug
Submitted by
admin
on September 12, 2012 - 12:28pm
Source:
Reuters
News Tags:
Lundbeck
FDA
schizophrenia
aripiprazole
Headline:
Lundbeck says FDA accepts review of schizophrenia drug
Do Not Allow Advertisers to Use My Personal information
